Timeline

Paul-Henri Consigny

Head of Structure

01 Aug 2025

publication

Phylogenetic analysis of chikungunya virus in travellers returning from La Reunion Island.

01 Jan 2025

publication

Rabies exposure in international travellers: Experience from a single travel clinic in Paris, France, 2018-2022.

15 Jul 2024

project

Prophylaxies post-exposition contre la rage chez les voyageurs,à propos de 2916 patients vus au centre antirabique de l’Institut Pasteur de Paris, 2018-2022

18 Jun 2024

project

Surveillance et étude des maladies au retour de voyage dans le cadre du réseau GeoSentinel

03 May 2024

project

Étude Observationnelle des Pathologies des voyageurs, EOP

29 Mar 2024

publication

Health problems and exposure to infectious risks in returning humanitarian aid workers.

18 Mar 2024

project

Problèmes de santé chez les travailleurs humanitaires

14 Feb 2024

project

SUMMIT

19 Jan 2024

news

CORSER4 : étude sur les personnes en cours de vaccination contre la COVID-19

09 Sep 2022

project

PoxVac22 – Description of the kinetics of the clinical and biological aspects of the persons consulting in the framework of the management of the MONKEYPOX disease

26 Jun 2020

news

Curie-O-SA : étude de la réponse immunitaire contre le virus SARS-CoV2

10 Jan 2020

publication

Rifampin-moxifloxacin-metronidazole combination therapy for severe Hurley Stage 1 Hidradenitis Suppurativa: prospective short-term trial and one-year follow-up in 28 consecutive patients.

03 Jul 2019

project

Projet ABCESS2 : A Multicentric Randomized Double-Blind Phase 3 Trial Evaluating the Efficacy of an Adapted Antibiotherapy in Hurley Stage 2 Active Hidradenitis Suppurativa Patients versus Tetracycline Derivative

26 Mar 2019

project

Dat’AIDS cohort: use of data from NADIS® specialty medical records completed in real time during consultations

26 Mar 2019

project

Patients with a particular immunological/virological profile (long-term asymptomatic, spontaneous controllers, post-treatment controllers): ANRS CO21 CODEX cohort including the iVISCONTI study

26 Mar 2019

project

Patients managed from the first infection: Cohort ANRS CO6 PRIMO

26 Mar 2019

project

ANRS CO4 FHDH

03 Feb 2017

project

InterVax

29 Nov 2016

team

Medical Center of the Institut Pasteur

01 Nov 2015

publication

Bacteriology of hidradenitis suppurativa/acne inversa: A review

25 Jun 2015

publication

Is granulomatous mastitis a localized form of hidradenitis suppurativa?

29 May 2015

publication

[The pregnant traveller]

22 Apr 2015

publication

High Rate of Acquisition but Short Duration of Carriage of Multidrug-Resistant Enterobacteriaceae After Travel to the Tropics

01 Dec 2014

publication

[Malaria]

01 Dec 2014

publication

[Plasmodium resistance to antimalarials]

01 Dec 2014

publication

Bacterial pathogens associated with hidradenitis suppurativa, France.

15 Nov 2014

publication

Prevention of infections during primary immunodeficiency.

11 Nov 2014

publication

No booster dose for yellow fever vaccination: what are the consequences for the activity of vaccination in travel clinics?

17 Jul 2014

publication

Hepatitis B screening in travelers: a retrospective analysis

10 Apr 2014

publication

Acquisition of carbapenemase-producing Enterobacteriaceae by healthy travellers to India, France, February 2012 to March 2013

24 Jan 2014

publication

A. Dramatic reduction of clindamycin plasma concentration in hidradenitis suppurativa patients treated with the rifampin-clindamycin combination.

01 Jan 2014

publication

Dramatic reduction of clindamycin plasma concentration in hidradenitis suppurativa patients treated with the rifampin-clindamycin combination

07 Nov 2013

publication

Atovaquone-proguanil in the treatment of imported uncomplicated Plasmodium falciparum malaria: a prospective observational study of 553 cases

01 Sep 2013

publication

Safety and immunogenicity of yellow fever 17D vaccine in adults receiving systemic corticosteroid therapy: an observational cohort study

08 Jul 2013

publication

Persistence of yellow fever vaccine-induced antibodies after solid organ transplantation

01 Mar 2013

publication

Fungal infections in immunocompromised travelers.

23 Oct 2012

publication

[61-year-old woman with formation of nodules after a tropical journey]

01 Jul 2012

publication

Tick-borne relapsing fever with cutaneous eschar and radiculopathy, Ethiopia

18 Feb 2011

publication

[Long term persistence of yellow fever neutralising antibodies in elderly persons]

07 Feb 2011

publication

Hepatitis A seroprevalence in a population of immigrants at a French vaccination center

25 Nov 2010

publication

Efficacy of rifampin-moxifloxacin-metronidazole combination therapy in hidradenitis suppurativa

25 Nov 2010

publication

Efficacy of rifampin-moxifloxacin-metronidazole combination therapy in hidradenitis suppurativa. Dermatology

27 Oct 2010

publication

Comparison of knowledge on travel related health risks and their prevention among humanitarian aid workers and other travellers consulting at the Institut Pasteur travel clinic in Paris, France

01 Apr 2010

publication

[Long-term seroprotection against Japanese encephalitis using an inactivated vaccine (Jevax)]

09 Feb 2010

publication

[Influenza virus A/H1N1 infection: wrong provisional diagnosis.[corrected]]

01 Nov 2009

publication

Unusual location of an inoculation lesion in a traveler with African tick-bite fever returning from South Africa

01 Nov 2009

publication

Rickettsia africae infection in man after travel to Ethiopia

01 Oct 2009

publication

Cervical schistosomiasis as a risk factor of cervical uterine dysplasia in a traveler.

15 Jun 2009

publication

Is granulomatous mastitis a localized form of hidradenitis suppurativa?

01 Mar 2009

publication

Pristinamycin for Rickettsia africae infection.

25 Dec 2008

publication

[Vaccinations for the traveling adult solid organ transplant recipient (excluding hematopoietic stem cell transplant recipients)]

10 Jan 2008

publication

Two unusual glandular presentations of tick-borne tularemia.

01 Oct 2007

publication

[Chikungunya virus infection: lessons from genomic analysis]

21 Sep 2007

publication

[Antiviral immunization of immunocompromised adults, literature review]

01 May 2007

publication

Genital schistosomiasis in a traveler coming back from Mali

01 Apr 2006

publication

[Chikungunya virus: a reemerging alphavirus].

15 Jan 2006

publication

[Travel in tropical countries. Advice before start, diseases on return: fever, diarrhea]

01 Nov 2005

publication

African tick-bite fever in French travelers

15 Mar 2003

publication

[Management of patients infected with HIV]

01 Jan 2002

publication

High prevalence of co-factor independent anticardiolipin antibodies in malaria exposed individuals

01 Nov 1997

publication

A little guide for advanced search:

Phylogenetic analysis of chikungunya virus in travellers returning from La Reunion Island.

Rabies exposure in international travellers: Experience from a single travel clinic in Paris, France, 2018-2022.

Prophylaxies post-exposition contre la rage chez les voyageurs,à propos de 2916 patients vus au centre antirabique de l’Institut Pasteur de Paris, 2018-2022

Surveillance et étude des maladies au retour de voyage dans le cadre du réseau GeoSentinel

Étude Observationnelle des Pathologies des voyageurs, EOP

Health problems and exposure to infectious risks in returning humanitarian aid workers.

Problèmes de santé chez les travailleurs humanitaires

SUMMIT

CORSER4 : étude sur les personnes en cours de vaccination contre la COVID-19

PoxVac22 – Description of the kinetics of the clinical and biological aspects of the persons consulting in the framework of the management of the MONKEYPOX disease

Curie-O-SA : étude de la réponse immunitaire contre le virus SARS-CoV2

Rifampin-moxifloxacin-metronidazole combination therapy for severe Hurley Stage 1 Hidradenitis Suppurativa: prospective short-term trial and one-year follow-up in 28 consecutive patients.

Projet ABCESS2 : A Multicentric Randomized Double-Blind Phase 3 Trial Evaluating the Efficacy of an Adapted Antibiotherapy in Hurley Stage 2 Active Hidradenitis Suppurativa Patients versus Tetracycline Derivative

Dat’AIDS cohort: use of data from NADIS® specialty medical records completed in real time during consultations

Patients with a particular immunological/virological profile (long-term asymptomatic, spontaneous controllers, post-treatment controllers): ANRS CO21 CODEX cohort including the iVISCONTI study

Patients managed from the first infection: Cohort ANRS CO6 PRIMO

ANRS CO4 FHDH

InterVax

Medical Center of the Institut Pasteur

Bacteriology of hidradenitis suppurativa/acne inversa: A review

Is granulomatous mastitis a localized form of hidradenitis suppurativa?

[The pregnant traveller]

High Rate of Acquisition but Short Duration of Carriage of Multidrug-Resistant Enterobacteriaceae After Travel to the Tropics

[Malaria]

[Plasmodium resistance to antimalarials]

Bacterial pathogens associated with hidradenitis suppurativa, France.

Prevention of infections during primary immunodeficiency.

No booster dose for yellow fever vaccination: what are the consequences for the activity of vaccination in travel clinics?

Hepatitis B screening in travelers: a retrospective analysis

Acquisition of carbapenemase-producing Enterobacteriaceae by healthy travellers to India, France, February 2012 to March 2013

A. Dramatic reduction of clindamycin plasma concentration in hidradenitis suppurativa patients treated with the rifampin-clindamycin combination.

Dramatic reduction of clindamycin plasma concentration in hidradenitis suppurativa patients treated with the rifampin-clindamycin combination

Atovaquone-proguanil in the treatment of imported uncomplicated Plasmodium falciparum malaria: a prospective observational study of 553 cases

Safety and immunogenicity of yellow fever 17D vaccine in adults receiving systemic corticosteroid therapy: an observational cohort study

Persistence of yellow fever vaccine-induced antibodies after solid organ transplantation

Fungal infections in immunocompromised travelers.

[61-year-old woman with formation of nodules after a tropical journey]

Tick-borne relapsing fever with cutaneous eschar and radiculopathy, Ethiopia

[Long term persistence of yellow fever neutralising antibodies in elderly persons]

Hepatitis A seroprevalence in a population of immigrants at a French vaccination center

Efficacy of rifampin-moxifloxacin-metronidazole combination therapy in hidradenitis suppurativa

Efficacy of rifampin-moxifloxacin-metronidazole combination therapy in hidradenitis suppurativa. Dermatology

Comparison of knowledge on travel related health risks and their prevention among humanitarian aid workers and other travellers consulting at the Institut Pasteur travel clinic in Paris, France

[Long-term seroprotection against Japanese encephalitis using an inactivated vaccine (Jevax)]

[Influenza virus A/H1N1 infection: wrong provisional diagnosis.[corrected]]

Unusual location of an inoculation lesion in a traveler with African tick-bite fever returning from South Africa

Rickettsia africae infection in man after travel to Ethiopia

Cervical schistosomiasis as a risk factor of cervical uterine dysplasia in a traveler.

Is granulomatous mastitis a localized form of hidradenitis suppurativa?

Pristinamycin for Rickettsia africae infection.

[Vaccinations for the traveling adult solid organ transplant recipient (excluding hematopoietic stem cell transplant recipients)]

Two unusual glandular presentations of tick-borne tularemia.

[Chikungunya virus infection: lessons from genomic analysis]

[Antiviral immunization of immunocompromised adults, literature review]

Genital schistosomiasis in a traveler coming back from Mali

[Chikungunya virus: a reemerging alphavirus].

[Travel in tropical countries. Advice before start, diseases on return: fever, diarrhea]

African tick-bite fever in French travelers

[Management of patients infected with HIV]

High prevalence of co-factor independent anticardiolipin antibodies in malaria exposed individuals

[Bifocal mediastinal opacity]